Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-clinical Participants”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05722015
What this trial is testing

Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 377
Not applicableLooking for participantsNCT07746583
What this trial is testing

Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice

Who this might be right for
Psoriasis
Janssen-Cilag Kft. 100
Early research (Phase 1)Study completedNCT03255096
What this trial is testing

Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell Lymphoma With MYC and/or BCL2 and/or BCL6

Who this might be right for
Diffuse Large B-cell LymphomaHigh-Grade B-cell Lymphoma
Hoffmann-La Roche 39
Not applicableActive Not RecruitingNCT04764188
What this trial is testing

An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib

Who this might be right for
NSCLC
Hoffmann-La Roche 800
Large-scale testing (Phase 3)Looking for participantsNCT07634471
What this trial is testing

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

Who this might be right for
Follicular Lymphoma
Merck Sharp & Dohme LLC 960
Not applicableStudy completedNCT03942263
What this trial is testing

Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation

Who this might be right for
Hodgkin DiseaseLymphoma, Large-cell, Anaplastic
Takeda 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06637423
What this trial is testing

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 32
Testing effectiveness (Phase 2)Looking for participantsNCT06800963
What this trial is testing

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Who this might be right for
NMIBC
ImmunityBio, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT04704219
What this trial is testing

Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 160
Large-scale testing (Phase 3)Active Not RecruitingNCT06212752
What this trial is testing

Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 39
Testing effectiveness (Phase 2)Study completedNCT02875548
What this trial is testing

Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Synovial Sarcoma+5 more
Epizyme, Inc. 58
Not applicableWithdrawnNCT04243031
What this trial is testing

QuantiFERON Access Clinical Performance Study Protocol

Who this might be right for
Tuberculosis (TB)
QIAGEN Gaithersburg, Inc
Large-scale testing (Phase 3)Looking for participantsNCT05645107
What this trial is testing

Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Who this might be right for
HypogammaglobulinemiaBacterial InfectionsB-cell Chronic Lymphocytic Leukemia+2 more
Grifols Therapeutics LLC 386
Large-scale testing (Phase 3)Looking for participantsNCT07266831
What this trial is testing

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC 570
Early research (Phase 1)Study completedNCT07787728
What this trial is testing

Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or Obesity

Who this might be right for
Overweight , Obesity
Shanghai Minwei Biotechnology Co., Ltd 40
Large-scale testing (Phase 3)Active Not RecruitingNCT07473960
What this trial is testing

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Innovent Biologics (Suzhou) Co. Ltd. 198
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07607925
What this trial is testing

Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07796477
What this trial is testing

SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
CSPC Ouyi Pharmaceutical Co., Ltd. 240
Not applicableStudy completedNCT01839500
What this trial is testing

A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 1,600
Large-scale testing (Phase 3)Ended earlyNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Next Page